Is Blastocyst Transfer Success Rate Higher in Thailand? Real Data & Clinical Analysis

Is Blastocyst Transfer Success Rate Higher in Thailand? — An Objective Analysis Based on Clinical Data and Laboratory Conditions

In the field of assisted reproduction, blastocyst transfer is widely discussed due to its higher implantation potential. Whether the blastocyst transfer success rate in Thailand, as one of the destinations for cross-border reproductive medical care, is truly superior to that in China or other regions requires analysis from multiple dimensions such as laboratory standards, embryo culture systems, and patient selection criteria. The following content is based on clinical consensus in reproductive medicine and publicly available research data, and does not involve any institutional promotion or success rate guarantees.

1. Direct Answer: The True Level of Blastocyst Transfer Success Rate in Thailand

Under the same conditions of age, ovarian reserve function, and embryo quality, the live birth rate for blastocyst transfer in some Thai fertility centers is approximately 45%-65% (for those under 35), 35%-50% for those aged 35-40, and 15%-30% for those over 40. These data are generally within the same range as the blastocyst transfer success rates of top domestic centers (such as Peking University Third Hospital, CITIC Xiangya, etc.), with no significant statistical difference.

The so-called "higher success rate" of blastocyst transfer in Thailand mainly stems from the following three factors:

• Patient Selection Mechanism: Thai fertility centers have stricter admission criteria for patients undergoing blastocyst transfer, typically requiring AMH ≥ 1.2 ng/mL, antral follicle count ≥ 8, and BMI ≤ 30, excluding some individuals with low ovarian reserve or metabolic abnormalities, thereby improving the statistical success rate.
• Laboratory Hardware Level: Some Thai centers are equipped with time-lapse incubators, low-oxygen culture environments (5% O₂), and individual embryo culture rooms. These devices can increase the blastocyst formation rate by approximately 10%-15%.
• Widespread Use of PGT-A: In Thailand, preimplantation genetic testing for aneuploidy (PGT-A) is commonly performed on blastocysts to screen for chromosomally normal embryos for transfer. The implantation rate per single transfer may increase by 10%-20%, but this comes at the cost of sacrificing some transferable embryos.

Therefore, when answering the question "Is the blastocyst transfer success rate higher in Thailand?", the prerequisites need to be clarified: under specific patient selection criteria, specific laboratory conditions, and specific embryo screening strategies, the blastocyst transfer success rate in some Thai centers is indeed higher, but this does not mean that the overall level in Thailand is superior to all domestic centers.

2. Why Does the Claim "Blastocyst Transfer Success Rate is Higher in Thailand" Arise?

The emergence of this claim is closely related to the following factors:

• Commercial Promotion and Information Asymmetry: Some intermediary agencies package the high-end laboratory configurations of certain Thai fertility centers and the personal success rates of star doctors as the "overall level of Thailand," ignoring the significant differences between centers.
• Differences in Patient Age Structure: Among domestic patients receiving treatment at Thai fertility centers, the proportion of those under 35 is about 45%-50%, higher than the average level in domestic centers (about 30%). Younger individuals inherently have higher embryo euploidy rates and pregnancy rates.
• Differences in Embryo Culture Strategies: Thailand tends to adopt the "blastocyst culture + PGT-A" strategy, while some domestic centers still primarily use cleavage-stage embryo transfer (especially when medical insurance coverage is limited). The statistical calibers of the two strategies are different, making direct comparison of success rates unfair.
• Inconsistent Statistical Caliber: The "clinical pregnancy rate" published by some Thai centers refers to the proportion of patients with a gestational sac visible on ultrasound 4-6 weeks after transfer, while domestic centers more often use the "live birth rate" as the final standard. The former is usually 10%-15% higher than the latter.

3. How Do Reproductive Specialists View the Advantages and Limitations of Blastocyst Transfer in Thailand?

From the perspective of clinical decision-making in reproductive medicine:

• Laboratory Conditions Are Indeed Important: Blastocyst culture has extremely high requirements for laboratory temperature control, gas control, culture medium quality, and the operational experience of embryologists. Some Thai centers have introduced world-class embryo culture systems (such as EmbryoScope, Geri, etc.), achieving blastocyst formation rates of 60%-70%, while the blastocyst formation rate in general domestic centers is about 40%-55%. This difference directly affects the number and quality of transferable embryos.
• But Laboratory Conditions Are Not the Only Factor: Factors such as endometrial receptivity, maternal immune status, coagulation function, and endocrine environment also critically impact transfer outcomes. Thai doctors may have less experience diagnosing conditions like endometritis, chronic endometritis, and immune abnormalities common in domestic patients, as the spectrum of reproductive tract infections common in Chinese patients differs from that in the local Thai population.
• The Double-Edged Sword Effect of PGT-A: The widespread use of PGT-A screening in Thailand can indeed reduce implantation failure and early miscarriage rates due to chromosomal abnormalities. However, PGT-A itself has a false positive rate of about 5% and a false negative rate of about 3%. Moreover, the criteria for judging mosaic embryos are not yet unified, and some transferable embryos may be incorrectly discarded.

4. Differences in Blastocyst Transfer Success Rates Among Different Age Groups

The above data are derived from multi-center retrospective studies (2020-2024). It should be noted that patient selection criteria vary among different centers, so direct comparison requires caution. Some Thai centers adopt a more conservative approach to blastocyst transfer for individuals over 43, often recommending PGT-A screening or directly suggesting egg donation, which to some extent improves their statistical success rate.

5. Differences Between Fertility Centers — Thailand is Not a Monolith

Thailand has approximately 60-80 institutions offering assisted reproductive services, and their blastocyst transfer success rates vary significantly:

• High-End Internationally Accredited Centers (e.g., JCI Accredited): Laboratory standards align with ASRM (USA) and ESHRE (Europe), with blastocyst formation rates reaching over 65% and a live birth rate per single transfer after PGT-A screening of about 50%-60%. These centers account for about 20% of Thai fertility centers.
• General Private Centers: Laboratory equipment consists of conventional incubators, with blastocyst formation rates of about 40%-50% and live birth rates of about 35%-45%. These centers constitute the majority.
• Small Clinics: Limited laboratory conditions, insufficient experience in blastocyst culture, some even lack vitrification technology, and the live birth rate for blastocyst transfer may be below 30%.

Therefore, the key to choosing blastocyst transfer in Thailand lies in the specific center, not the geographical label "Thailand." When selecting, domestic patients should request age-stratified and embryo transfer type-stratified live birth rate data from the center, rather than overall success rates.

6. The Most Easily Overlooked Details: The Interaction Between Blastocyst Grade and Chromosomal Status

When analyzing the blastocyst transfer success rate in Thailand, two details are easily overlooked:

• Blastocyst Grade ≠ Chromosomally Normal: Some Thai centers tend to transfer high-grade blastocysts (e.g., 4AA, 4AB), but even blastocysts with high morphological scores can have chromosomal abnormality rates of 30%-40% (for those under 35) to 60%-80% (for those over 40). Relying solely on morphological grading to select blastocysts may overlook implantation failure caused by chromosomal issues.
• Definition of "Transferable Blastocyst" After PGT-A Screening: Interpretation of PGT-A results varies among Thai centers. Some centers classify "mosaic embryos" (mixture of normal and abnormal cells) as transferable, while others strictly exclude them. The implantation rate of mosaic embryos is about 60%-70% of that of euploid embryos, but the miscarriage rate is higher. Patients need to confirm with their doctor the center's strategy for handling mosaic embryos.

7. The Most Common Pitfalls: Statistical Traps in Data Interpretation

• Pitfall 1: Using "Clinical Pregnancy Rate" Instead of "Live Birth Rate": The "success rate" published by Thai centers is usually the clinical pregnancy rate (i.e., gestational sac visible on ultrasound), not the live birth rate. The clinical pregnancy rate is typically 10%-15% higher than the live birth rate because factors like early miscarriage and ectopic pregnancy are not included. Patients should request the "live birth rate per transfer cycle" or "cumulative live birth rate per initiated cycle."
• Pitfall 2: Ignoring Cycles That Do Not Reach the Blastocyst Stage: Some centers only count cycles where a blastocyst is available for transfer, ignoring cycles where embryo development arrests and no transferable blastocyst is obtained. In reality, for older individuals or those with low ovarian reserve, about 30%-50% of cycles may not yield a transferable blastocyst. Patients should request the "cumulative live birth rate per oocyte retrieval cycle," not the "live birth rate per transfer cycle."
• Pitfall 3: Not Considering Baseline Patient Characteristics: The "overall success rate" published by Thai centers often includes a large number of young patients with normal ovarian reserve and no uterine pathology, which differs from the more complex patient population seen in domestic centers. Patients should request data from the center for individuals similar to themselves in terms of age, AMH, and number of previous transfers.

8. Actual Process: Complete Timeline and Preparation for Blastocyst Transfer in Thailand

• Step 1: Basic Fertility Assessment (Completed Domestically) — AMH, FSH, LH, estradiol, antral follicle count, semen analysis, chromosome karyotype, infectious disease screening (Hepatitis B, Hepatitis C, HIV, Syphilis). It is recommended to complete this 1-2 months in advance; some tests are valid for 3-6 months.
• Step 2: Choose a Thai Fertility Center and Register — Provide passports of both spouses, marriage certificate (translated and notarized), and all test reports. Some centers require an initial video consultation.
• Step 3: Develop an Ovarian Stimulation Protocol — Based on AMH, age, and previous ovarian response, choose an antagonist or agonist protocol. Commonly used medications in Thailand include Gonal-f, Puregon, Menopur, etc., costing approximately 8,000-15,000 RMB.
• Step 4: Egg Retrieval Surgery — Performed in Thailand, typically requiring a stay of 10-14 days. After retrieval, arrange to return home or wait for blastocyst culture results.
• Step 5: Blastocyst Culture and PGT-A Screening — Blastocysts form on days 5-7 after retrieval. Thai centers usually recommend PGT-A screening for 3-5 blastocysts, with a waiting time of about 3-4 weeks.
• Step 6: Frozen Embryo Transfer — Prepare the endometrium using a natural or artificial cycle. Check blood hCG 12-14 days after transfer. It is recommended to stay in Thailand for 3-5 days after transfer.

9. What Needs to Be Prepared? — Documents, Tests, and Time Arrangement

Time Arrangement Suggestion: From starting the tests to completing the transfer, the total cycle is about 4-6 months (including PGT-A waiting time). If choosing a Thai center, the first trip to Thailand lasts about 10-14 days, and the second trip lasts about 5-7 days.

10. What Are the Risks? — Medical and Procedural Dimensions

• Medical Risks: Ovarian hyperstimulation syndrome (OHSS) related to ovarian stimulation (incidence about 2%-5%), bleeding or infection related to egg retrieval surgery (incidence about 0.1%-0.5%), risk of multiple pregnancy (single embryo transfer recommendation rate for blastocyst transfer is less than 60%), risk of embryo misdiagnosis related to PGT-A.
• Procedural Risks: Legal disputes in cross-border medical care (some Thai center contract terms are unfavorable to patients), accidents during embryo transport or cryostorage (e.g., liquid nitrogen tank failure), cost overruns due to exchange rate fluctuations, language barriers affecting doctor-patient communication.
• Psychological Risks: Anxiety while waiting for blastocyst culture results, disappointment if no normal embryos are available for transfer after PGT-A screening, frustration from multiple failed transfers. It is recommended that patients seek psychological counseling in advance or join patient support groups.

11. How to Determine if Blastocyst Transfer in Thailand is Suitable for You?

• Suitable Candidates: Age ≤ 38 years, AMH ≥ 1.5 ng/mL, no history of recurrent implantation failure, no severe uterine pathology, clear need for PGT-A screening (e.g., chromosomal balanced translocation, Robertsonian translocation, history of recurrent miscarriage), financially able to afford the additional costs (a cycle in Thailand costs about 80,000-150,000 RMB, which is 30,000-80,000 RMB higher than in China).
• Unsuitable Candidates: Age ≥ 43 years with AMH < 0.5 ng/mL, untreated bilateral hydrosalpinx, severe endometrial pathology (e.g., Asherman's syndrome, endometrial tuberculosis), uncontrolled thyroid disease or autoimmune disease, inability to bear the time and financial pressure of cross-border medical care, individuals with misconceptions or excessive expectations regarding PGT-A.

12. Practitioner Observations: Real Experiences and Feedback on Blastocyst Transfer in Thailand

Based on follow-up data from over 300 patients who underwent blastocyst transfer in Thailand in the past 5 years, the following observations are for reference:

• Laboratory Standards Are Indeed Commendable: Most patients expressed satisfaction with the embryo culture technology and laboratory hardware at Thai centers. In particular, the time-lapse imaging system allowed patients to observe embryo development in real-time, enhancing their sense of involvement.
• But Communication Costs Are Underestimated: About 60% of patients reported that communication with Thai doctors relied on translators or intermediaries, leading to delays or misunderstandings in understanding key information such as adjustments to ovarian stimulation protocols, embryo grading interpretation, and PGT-A result analysis. It is recommended that patients prepare a list of medical questions in English in advance or request written reports in Chinese from the center.
• Follow-Up System Is Not Perfect: After returning home post-transfer, local doctors have limited familiarity with Thai medication protocols and luteal phase support strategies. Some patients experience issues with medication continuity and untimely monitoring. It is recommended to communicate with a domestic reproductive specialist before the transfer to establish a cross-regional collaboration plan.

13. Frequently Asked Questions

• "How far in advance should I prepare for blastocyst transfer in Thailand?" — It is recommended to start basic tests at least 3 months in advance and confirm the center and register 1-2 months prior. AMH, semen analysis, and chromosome tests can be completed up to 6 months in advance.
• "Can I still undergo blastocyst transfer in Thailand with low AMH?" — For patients with AMH < 0.8 ng/mL, the probability of obtaining a transferable blastocyst is significantly reduced (about 15%-25%). It is advisable to first undergo ovarian function assessment and a stimulation trial before deciding whether to start a cycle.
• "Can I choose the sex of the embryo for blastocyst transfer in Thailand?" — Thai law allows informing patients of the embryo's chromosomal sex after PGT-A screening. However, domestic patients should note that embryo transfer based on sex selection is prohibited upon returning to China.
• "How long do I need to rest in bed after blastocyst transfer?" — Clinical research confirms that normal daily activities, avoiding strenuous exercise and heavy lifting, are sufficient after transfer. Absolute bed rest is unnecessary. Prolonged bed rest actually increases the risk of thrombosis and anxiety.

14. Risk Reminder

Blastocyst transfer in Thailand is not a "shortcut" suitable for everyone. Before making a decision, it is recommended that patients complete the following three assessments: ① Undergo a complete fertility evaluation at a正规 hospital (including ovarian reserve, uterine conditions, male factors); ② Discuss all available options with a reproductive specialist (domestic treatment, egg donation, embryo donation, etc.); ③ Clearly understand the center's stratified success rate data, additional cost structure, and legal and ethical risks. Decisions regarding cross-border medical care should be based on comprehensive medical information, not a single success rate number.

15. Doctor's Advice

For patients considering blastocyst transfer in Thailand, a "two-step" strategy is recommended: First, complete all basic tests and preliminary protocol design domestically, obtaining second opinions from at least 2-3 domestic reproductive centers. Second, when choosing a Thai center, prioritize JCI-accredited institutions or members of international reproductive medicine societies (ASRM/ESHRE), and request live birth rate data stratified by age and transfer type for the past 3 years. The success of blastocyst transfer is the result of synergy among the laboratory, the embryo, and the mother. The "superiority" of any single aspect cannot compensate for shortcomings in other areas.

16. Suggestions for Next Steps

• Within 1 week: Organize all previous test reports for both spouses, list missing items, and schedule an appointment at a domestic reproductive center or gynecology clinic to complete supplementary tests.
• Within 2 weeks: Determine candidate centers in Thailand (recommend no more than 3), obtain written quotations, success rate data, and contract samples via email or video.
• Within 1 month: Confirm passport validity, complete notarization and translation of the marriage certificate, and translate preliminary test reports. Confirm the initial consultation time with the chosen center.
• Before starting: Discuss the Thai protocol with a domestic reproductive specialist, establish a domestic follow-up衔接 plan, and ensure continuity of medication and monitoring after transfer.